Viewing Study NCT01356693


Ignite Creation Date: 2025-12-25 @ 1:01 AM
Ignite Modification Date: 2025-12-26 @ 1:20 PM
Study NCT ID: NCT01356693
Status: UNKNOWN
Last Update Posted: 2011-06-28
First Post: 2011-05-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bromelin, a Compound Prepared With Ananas Comocus Extract and Honey, for Acute Cough
Sponsor: Universidade Federal de Pernambuco
Organization:

Study Overview

Official Title: Randomized,Double-blind, Placebo Controlled Clinical Trial to Evaluate the Efficacy of the Phytotherapic Compound "Bromelin" on Acute Irritative Cough
Status: UNKNOWN
Status Verified Date: 2011-03
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: BROMETOSS
Brief Summary: Cough is the most bothersome symptom for patients with the common cold.

The objective of the study is to compare the phytotherapic "Bromelin", a compound preparation of honey from the bee apis mellifera with the extract of the pineapple (Ananas comosus) with placebo in reducing cough episodes in patients with the common cold.
Detailed Description: Common cold is very frequent and cough is one of the most troublesome symptoms. Over-the-counter medications are used by patients without prescription, many times with important side effects.

Bromelin, a compound made with honey and pineapple extract could offer cough symptomatic relief as a soothing agent.

This study aims to compare this compound with placebo in reducing cough in patients with common cold in an clinical trial designed in conformity to CONSORT guidelines.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: